Home » Topics » Regulatory

Regulatory
RSS

Climara Pro approved for prevention of postmenopausal osteoporosis

Jan. 9, 2006

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

Femara receives new U.S. approval

Dec. 30, 2005

Revlimid receives FDA approval

Dec. 29, 2005

Orencia approved for rheumatoid arthritis

Dec. 28, 2005

Nexavar receives FDA approval for advanced renal cell carcinoma

Dec. 22, 2005

Depakote ER receives new approval in bipolar disorder

Dec. 19, 2005

Iplex approved for severe primary IGF-1 deficiency

Dec. 15, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

U.K. approval for MT-100 for migraine

Nov. 29, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.